T1	SNP 0 19	Functional variants
T2	Cancer 48 61	breast cancer
T3	Entity 27 32	11q13
R1	SNP_location Arg1:T1 Arg2:T3	
T4	Association 33 43	risk locus
E1	Association:T4 snp_int:T1 bc:T2
T5	Gene_Regulation 62 70;81 120	regulate expression through long-range enhancers
E2	Gene_Regulation:T5 Theme:T6 Agent:T1
T6	Entity 71 80	cyclin D1
T7	Entity 100 120	long-range enhancers
T8	Entity 159 176	European subjects
T9	Entity 380 388	G allele
T10	SNP 429 437	rs554219
R2	SNP_allele Arg1:T10 Arg2:T9	
T11	Effect_Type 438 447	increases
T12	Association 448 452	risk
E3	Association:T12 snp_int:T10 bc:T14
A1	Effect_Type E3 Increase
R3	Effect_type_marker Arg1:E3 Arg2:T11	
T13	Entity 334 366	transcriptional enhancer element
T14	Cancer 456 469	breast cancer
T15	Gene_Regulation 484 491	binding
E4	Gene_Regulation:T15 Theme:T17
T16	Effect_Type 471 478	reduces
A2	Effect_Type E4 Decrease
R4	Effect_type_marker Arg1:E4 Arg2:T16	
T17	Entity 495 520	ELK4 transcription factor
T18	Entity 525 535	luciferase
T19	Organic_inorganic_molecules_affected 536 544	activity
E5	Organic_inorganic_molecules_affected:T19 Theme:T18 Agent:T10
A3	Effect_Type E5 Decrease
R5	Effect_type_marker Arg1:E5 Arg2:T16	
T20	Spec 569 572	may
T21	Organic_inorganic_molecules_affected 614 620	levels
E6	Organic_inorganic_molecules_affected:T21 Agent:T10 Theme:T23
R6	Speculation_marker Arg1:E6 Arg2:T20	
T22	Effect_Type 592 595	low
T23	Entity 596 613	cyclin D1 protein
R7	Effect_type_marker Arg1:E6 Arg2:T22	
A4	Effect_Type E6 Decrease
T24	Cell_types_tissues_affected 624 630	tumors
E7	Cell_types_tissues_affected:T24 Theme:T25 Agent:T10
T25	Entity 624 630	tumors
R8	SNP_location Arg1:T10 Arg2:T13	
T26	SNP 659 669	rs78540526
T27	Spec 640 649	candidate
T28	Association 411 420	causative
E8	Association:T28 
R9	Equiv Arg1:E8 Arg2:E3	
T29	Spec 401 410	candidate
T30	Level 396 400	best
R10	Speculation_marker Arg1:E8 Arg2:T29	
R11	Level_marker Arg1:E8 Arg2:T30	
A5	Level E8 High
T31	Association 640 649	candidate
E9	Association:T31 snp_int:T26 bc:T14
R12	Speculation_marker Arg1:E9 Arg2:T27	
T32	Entity 683 704	same enhancer element
R13	SNP_location Arg1:T26 Arg2:T32	
R14	Equiv Arg1:T32 Arg2:T13	
T33	SNP 140 148;217 222	variants three
R17	Population_assignment Arg1:T33 Arg2:T8	
T34	Interaction 223 234	independent
E10	Interaction:T34 Entity:T33
T35	Neg 223 234	independent
R18	Negation_marker Arg1:E10 Arg2:T35	
T36	Association 235 246	association
E11	Association:T36 snp_int:E10 bc:T37
T37	Cancer 259 292	estrogen-receptor-positive tumors
A6	Cancer_Type T37 ER+
T38	Entity 296 301	11q13
R20	SNP_location Arg1:T33 Arg2:T38	
R21	SNP_location Arg1:T10 Arg2:T38	
R22	SNP_location Arg1:T26 Arg2:T38	
T39	Entity 259 276	estrogen-receptor
T40	Effect_Type 277 285	positive
T41	Organic_inorganic_molecules_affected 235 246	association
E12	Organic_inorganic_molecules_affected:T41 Theme:T39 Agent:T33
A7	Effect_Type E12 Increase
R23	Effect_type_marker Arg1:E12 Arg2:T40	
R24	Member Arg1:T33 Arg2:T42	
R25	Member Arg1:T33 Arg2:T10	
T42	SNP 733 743	rs75915166
T43	Association 711 722	association
E13	Association:T43 snp_int:T42 bc:T14
T44	Gene_Regulation 745 752;761 773	creates binding site
E14	Gene_Regulation:T44 Theme:T45 Theme2:T46 Agent:T42
T45	Entity 755 760	GATA3
T46	Entity 774 799	within a silencer element
T47	Gene_Regulation 886 894	interact
E15	Gene_Regulation:T47 Theme:T48 Theme2:T50 Theme3:T49 Agent:T33
T48	Entity 946 951	CCND1
T49	Entity 855 863	enhancer
T50	Entity 868 876	silencer
R15	Member Arg1:T33 Arg2:T26	
R16	SNP_location Arg1:T1 Arg2:T7	
